Competing biomedical HIV prevention strategies: potential cost‐effectiveness of HIV vaccines and PrEP in Seattle, WA-Reference-Cited by-同舟云学术

Competing biomedical HIV prevention strategies: potential cost‐effectiveness of HIV vaccines and PrEP in Seattle, WA

Author:

Adamson Blythe¹²³^ORCID,Garrison Louis¹,Barnabas Ruanne V²⁴,Carlson Josh J¹,Kublin James⁴⁵,Dimitrov Dobromir²

Affiliation:

1. Department of Pharmacy The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute University of Washington Seattle WA USA

2. Vaccine and Infectious Diseases Division Fred Hutchinson Cancer Research Center Seattle WA USA

3. Flatiron Health New York NY USA

4. Division of Allergy and Infectious Diseases Department of Global Health University of Washington Seattle WA USA

5. HIV Vaccine Trials Network Fred Hutchinson Cancer Research Center Seattle WA USA

Funder

Agency for Healthcare Research and Quality

National Institutes of Health

American Foundation for Pharmaceutical Education

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

Reference78 articles.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献